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6ABBREVIATIONS
ATCC American Type Culture Collection
ATP adenosine triphosphate
BEV bovine enterovirus
BFLA bafilomycin A
bp base pair
BSA bovine serum albumin
CAR coxsackievirus-adenovirus receptor
CAV coxsackievirus A
CBV coxsackievirus B
cDNA complementary DNA
CMC carboxymethylcellulose
CPE cytopathic effect
DAF decay-accelerating factor
E. coli Escherichia coli
FCS fetal calf serum
FMDV foot-and-mouth disease virus
GMK green monkey kidney cell line
GTP guanosine triphosphate
HeLa human tumor-derived cell line
HEp human epithelial carcinoma cell line
HEV human enterovirus
HRV human rhinovirus
ICAM intercellular adhesion molecule
IOD integrated optical density
IRES internal ribosome entry site
LLC Mk2 cell line of green monkey kidney origin
MAb monoclonal antibody
mCAR murine coxsackievirus-adenovirus receptor
MEM minimal essential medium
7nt nucleotide
p1, p2, p3 the three positions of a codon
PAGE polyacrylamide gel electrophoresis
PBS phosphate-buffered saline
PCR polymerase chain reaction
PDB protein data bank
PV poliovirus
PVR poliovirus receptor
RD human rhabdomyosarcoma cell line
RT-PCR reverse transcription - polymerase chain reaction
SDS sodium dodecyl sulfate
SVDV swine vesicular disease virus
TG1 E. coli strain used as the M13 host
Tm melting temperature
UTR untranslated region
VP viral protein
W/V weight/volume
8REVIEW OF THE LITERATURE
Enteroviruses
Enteroviruses form one of the most common groups of human pathogens, causing a
wide range of diseases. The clinical features include poliomyelitis and other
neurological diseases, meningitis, myocarditis, conjunctivitis, skin and mucosal
eruptions, diarrhea, generalized infections of the newborn, and common cold-like
illness. Many, if not most of the infections are subclinical, proceeding in a period of
several weeks without significant symptoms in the host, but rare cases result in
paralysis or even death. One of the peculiar features of enteroviruses is that there is
both individual and temporal variation in the diseases caused by various
enteroviruses. Most enterovirus serotypes, including coxsackievirus A9, may be
associated with several disease patterns. Recently, prospective seroepidemiological
studies have suggested a potential role of enterovirus infections in the etiology of
insulin-dependent diabetes mellitus (Hyöty et al. 1995, Hiltunen et al. 1997) and
atheroschlerotic heart disease (Roivainen et al. 1998)
The family Picornaviridae is formed by a large group of non-enveloped positive-
stranded RNA viruses. The genus Enterovirus forms one of the nine genera in the
family, the other eight being Aphthovirus, Cardiovirus, Erbovirus, Hepatovirus,
Kobuvirus, Parechovirus, Rhinovirus, and Teschovirus. Genetically, enteroviruses
cluster relatively closely with rhinoviruses, while the other genera are more distant
(for example Pöyry et al. 1996, Hyypiä et al. 1997, Oberste et al. 1999).
Enterovirus taxonomy has recently been changed in accordance with the increasing
genetic data (King et al. 1999). The current classification recognizes 87 serotypes in
the genus Enterovirus, 64 of these being human viruses. The human enterovirus
serotypes are divided into five species: the poliovirus species (PV), and the human
enteroviruses A to D (HEV-A to HEV-D). Enteroviruses have been isolated from
other animals as well, and some of these viruses form additional species.
9The enterovirus mainly studied in this thesis is coxsackievirus A9 (CAV9) which is
one of the most frequently isolated enteroviruses in clinical diseases (Hovi et al.
1996), and belongs to the species human enterovirus B (HEV-B) (King et al. 1999).
In addition to CAV9, this species consists of all coxsackievirus B serotypes (1-6),
all echoviruses (28 serotypes), and enterovirus 69. CAV9 is thus the only CAV
serotype in this species, the 22 other ones belonging to species HEV-A (11
serotypes) and HEV-C (11 serotypes) (King et al. 1999, Oberste et al. 1998, 1999).
The controversy between classification and nomenclature reflects the initially used
primitive classification system that was based on replication in cell cultures and
pathogenicity in experimental animals.
Table 1. Classification of human enteroviruses according to King et al. (1999).
Species Serotypes in the species
Poliovirus Human poliovirus 1-3
Human enterovirus A Human coxsackievirus A 2-8, 10, 12, 14, 16a
Human enterovirus 71
Human enterovirus B Human coxsackievirus A 9
Human coxsackievirus B 1-6
Human echovirus 1-7, 9, 11-21, 24-27, 29-33
Human enterovirus 69
Human enterovirus C Human coxsackievirus A 1, 11, 13, 15, 17-22, 24
Human enterovirus D Human enterovirus 68, 70
a
 CAV4 and CAV6 were unassigned in this work, but according to Oberste et al. (1998, 1999), they
belong to the HEV-A species.
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The knowledge about enterovirus biology comes mostly from studies concerning
poliovirus, information on other enteroviruses being much more limited, and rather
sporadic. In discussing the biology of enteroviruses, the focus is therefore in
poliovirus. Today, there is rather abundant genetic, and still, relatively narrow
experimental data giving assistance in educated guesses concerning other
enteroviruses.
Enterovirus structure
Enteroviruses are non-enveloped particles of about 30 nm diameter, composed of
sixty copies of each of the four structural proteins VP1 to VP4, that surround a
positive-stranded RNA genome of approximately 7500 nucleotides. The icosahedral
capsid contains 12 pentagon-shaped pentamers of 5 protomers, each protomer being
formed by one copy of each of the structural proteins. The basic organization of the
capsid is shared by all picornaviruses.
To date, atomic-resolution structures of six enteroviruses have been resolved by x-
ray crystallography. These structures include poliovirus 1 (PV1) (Hogle et al.
1985), PV3 (Filman et al. 1989), coxsackievirus B3 (CBV3) (Muckelbauer et al.
1995), bovine enterovirus (BEV) (Smyth et al. 1995), PV2 (Lentz et al. 1997), and
coxsackievirus A9 (CAV9) (Hendry et al. 1999). In addition, structures of human
rhinovirus 14 (HRV14; Rossmann et al. 1985, Arnold & Rossmann 1988), HRV1A
(Kim et al. 1989), HRV3 (Zhao et al. 1996), and HRV16 (Hadfield et al. 1997)
have been resolved. All these structures share a remarkable degree of overall
similarity, while variation is seen on the surface and on the inner structures of the
capsid. The major capsid proteins VP1 to VP3 are each folded into eight-stranded
antiparallel β-sheets with a jelly-roll topology. These β-barrels of five copies of
VP1 are located around the fivefold axis, while VP2 and VP3 are around the
threefold axis. VP4 is much smaller than the other structural proteins, having a less
11
ordered structure, and being located on the inner surface of the capsid, facing the
RNA.
Figure 1. Structural organization of an enterovirus.
a) Each protomer is formed by the proteolytic cleavage products of the P1 polyprotein, the
capsid proteins VP1 to VP4. The surface of the virion is formed by VP1, VP2 and VP3,
while VP4 is internal.
b) Five protomers assemble into a pentamer. The fivefold axis of the pentamer is shown.
c) An icosahedral capsid is formed by twelve pentamers. One of the twenty threefold axes
is marked. The capsid figure (1c) is adapted from Rueckert (1996).
One of the most striking structural features in picornaviruses is the circular canyon
around the fivefold axis, that was first seen in the structure of human rhinovirus 14
(HRV14) (Rossmann et al. 1985). The canyon hypothesis (Rossmann et al. 1985,
Rossmann 1989) suggests that one strategy to escape the immune surveillance of
the host organism would be to hide the receptor attachment site in a surface
depression. This would sterically protect the attachment site from antibodies, still
allowing recognition by the cell surface receptor that would be narrower than an
VP1
VP2
VP3
VP4
Fivefold axis
Threefold axis
a) Protomer                      b) Pentamer                c) Capsid
VP
1
VP2
VP
3
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antibody. The canyon is located roughly between VP1 on the ’north’ side (the side
closer to the fivefold axis), and VP2 and VP3 on the ‘south’ side. This organization
leaves five copies of VP1 as a protrusion at the fivefold axis. The general topology
of the canyon is variable, appearing more like five distinct depressions than a single
canyon in CAV9 (Hendry et al. 1999).
The N terminal glycine of VP4 has a myristate, a saturated tetradecanoic fatty acid,
covalently attached to it (Chow et al. 1987). In site-directed mutagenesis studies,
myristoylation and myristate-protein contacts were found to be necessary in
pentamer formation, RNA encapsidation (Moscufo et al. 1991), and for the stability
of the virion (Moscufo & Chow 1992). It was also shown that the VP4 protein is
necessary in uncoating or cell entry, as a nonviable VP4 mutant was capable of
forming the structural intermediates thought to be necessary for infection, and when
transfected to cells, the cDNA was capable of initiating infection that resulted in
apparently mature virions (Moscufo et al. 1993).
Figure 2. Molecular structure of coxsackievirus A9.
a) Spacefill model of a protomer seen at three different angles. VP1, cyan; VP2, yellow;
VP3, red; VP4, green; pocket factor, white; myristate, magenta.
b) Structures of individual capsid proteins (side view). In the upper panel, one protein is
shown as a spacefill model, while others are shown as wireframes. In the lower panel, the
individual proteins are shown as cartoon models with secondary structures highlighted, and
β-sheets shown in white.
c) Ribbon model of VP1 and the pocket factor. Wide strands show the positions of α-
helices and β-sheets, while narrow strands are turns and random coil.
Figures were generated by the RasMol 2.6 Molecular Visualisation Program by Roger
Sayle, Glaxo Wellcome Research and Development, Stevenage, Hertfordshire, U.K. The
CAV9 coordinates (Hendry et al. 1999) were from the Protein Data Bank (PDB) of the
Research Collaboratory for Structural Bioinformatics (RCSB) at http://www.rcsb.org/pdb/.
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All the known enterovirus and rhinovirus structures contain a hydrophobic pocket at
the base of the canyon, covered by loops of VP1 (Hendry et al. 1999). This space is
assumed to be normally filled by a natural pocket factor, a fatty acid with an
aliphatic chain of variable length. These pocket factors, including sphingosine
(PV1, PV3), palmitate (CBV3), and myristic acid (BEV), are believed to be present
in the virion upon release from the infected cell. The pocket factors are seen as
stabilizing agents in the capsid, and their presence is thought to prevent uncoating.
It is therefore necessary that these molecules should leave the pocket when infection
is initiated. This pocket is the site of action of several antiviral drugs and these are
thought to bind to the pocket more tightly than does a natural pocket factor, thereby
hindering uncoating (McSharry et al. 1979, Caliguiri et al. 1980, McKinlay 1985).
Enterovirus genome
Enteroviruses have a single molecule of positive-stranded RNA as their genome.
The RNA is about 7500 nucleotides long, and there is a small virus-encoded protein
VPg (or 3B) attached to the 5’ end of the molecule. At both the 5’ end and 3’ end of
the genome, there is an untranslated region (UTR). The 5’ UTR makes up
approximately 10 % of the genome. This 5’ UTR is involved in the initiation of
translation, directing ribosomes into the IRES, the internal ribosome entry site (Jang
et al. 1988, Pelletier and Sonenberg 1988). The 3’ UTR is shorter, only 70-100 nt in
length, and it is followed by a poly-A tail. The 3’ UTR is used in initiating the
synthesis of negative-strand RNA (Rohll et al. 1995), but even deletion mutants
lacking the 3’ UTR have been shown to be infectious in cell culture (Todd et al.
1997).
The protein coding region encodes a single polyprotein, which is proteolytically
cleaved into precursor proteins P1, P2 and P3, and thereafter into the structural
proteins VP1 to VP4 (P1), and seven nonstructural proteins (P2 and P3). Many of
the intermediate cleavage products are functional as well. Proteins 2A, 3C and 3CD
are proteases, 3D is the RNA-dependent RNA polymerase, 2C is apparently a
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helicase, and has a function in encapsidation of RNA (Vance et al. 1997), and 2B,
2BC, 3A and 3AB have been associated with various functions in the replication of
viral RNA.
Figure 3. The enterovirus genome.
P1, P2, and P3 are the products of the initial proteolytic cleavages of the viral polyprotein.
Overview of enterovirus replication cycle
In order to initiate an infectious cycle, the virus must attach to a cell surface
receptor on a susceptible cell. Upon binding to its receptor, an enterovirus
undergoes structural rearrangements resulting in a particle that has lost the majority
of the internal capsid protein VP4, has externalized the N terminus of VP1, and has
a different sedimentation coefficient (135S versus 160S of the native virion), altered
antigenic properties, and increased protease sensitivity. Some altered poliovirus
particles are found in endosomes soon after infection (Fenwick & Wall 1973), but
the entry site of a productive infection is still not known.
Before synthesizing complementary negative-stranded copies of the genome, the
genomic RNA acts as a template for protein synthesis. The viral proteins need to be
synthesized first to obtain the RNA-dependent RNA polymerase that the cellular
machinery lacks. Translation is initiated from the IRES present in the 5’ UTR (Jang
et al. 1988, Pelletier and Sonenberg 1988). The complete viral protein coding
region is translated as a single polyprotein, which is co-translationally cleaved, by
VP4 VP2    VP3       VP1      2A  2B        2C       3A 3B 3C         3D
 VPg 5’ncr                                                                                                                         3’ncr
A(n)
P1                            P2                            P3
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virus-encoded proteases, into three precursor proteins P1, P2 and P3 (Kitamura et
al. 1981). One of these, the capsid protein precursor P1, is co-translationally
myristoylated. The P2 and P3 proteins are cleaved into seven nonstructural proteins,
in addition to several forms of functional intermediates, acting in RNA replication
and protein processing. The P3 cleavage products include the proteases 3C and
3CD, that are needed in the cleavage of other virus proteins from the precursors.
The same RNA molecule that has been used in translation, is then used as a
template for synthesis of negative-stranded RNA molecules by the virus-encoded
polymerase 3D. These strands are then used in synthesizing large amounts of
positive-stranded copies that are used in translation of viral proteins, as well as
being encapsidated into the assembling virions. The small VPg protein is linked to
the 5’ end of all transcripts (Flanegan et al. 1977).
The infection process is enhanced by cleavage of the eukaryotic initiation factor
4GII (eIF4GII) (Gradi et al. 1998, Svitkin et al. 1999) and apparently the poly(A)-
binding protein as well (Kerekatte et al. 1999), by a mechanism that involves the
protease 2A (Hellen et al. 1991, Wyckoff et al. 1992). These cleavages are among
the known alterations in the host cell, resulting in cessation of cellular (cap-
dependent) protein synthesis by poorly understood mechanisms. Enteroviruses use a
different (cap-independent) method of translation initiation (Jang et al. 1988,
Pelletier and Sonenberg 1988), being therefore still capable of performing protein
synthesis in the infected cell.
The assembly of a new virion begins as the P1 precursor protein is cleaved into
capsid proteins VP0, VP1 and VP3, and these proteins form a heterotrimer (Korant
1973). Thereafter, five of these heterotrimers associate into a pentameric structure,
which is actually a 15-mer of five copies of each of the procapsid proteins VP0,
VP1 and VP3 (Phillips et al. 1968). Again, 12 of these pentamers then associate
together to form procapsids (VP01360) that are filled with a copy of the positive-
stranded genome. It is not known whether empty procapsids are first formed and
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then filled with the RNA molecule, or the procapsids associate around the RNA
molecule. Poliovirus and foot-and-mouth disease virus (FMDV) particles have been
reported to contain nonstructural proteins 2C, 3CD, 3C, and 3D, and although there
is no evidence of their usefulness, it has been suggested that their presence in the
virions might reflect a functional role in initiating replication in an infected cell
(Newman & Brown 1997). During encapsidation of the RNA, the majority of the
capsid protein VP0 is cleaved into VP2 and VP4. This is called the maturation
cleavage, which is thought to lock the assembled capsid into a stable, mature virion.
Poliovirus mutants that are unable to undergo this cleavage, are defective in
assembly and RNA encapsidation (Compton et al. 1990, Ansardi & Morrow 1995),
or can accumulate 150S particles that appear like procapsids filled with RNA, but
are highly unstable (Hindiyeh et al. 1999). Maturation cleavage is known to be
absent in parechoviruses 1 and 2, and in Aichi virus, demonstrating that this
cleavage is not an absolute requirement for all picornaviruses (Hyypiä et al. 1992,
Stanway et al. 1994, Yamashita et al. 1998). Empty capsids are also produced in
natural infection, and these particles have intact VP0 proteins instead of VP2 and
VP4, thus having the protein composition VP01360 (Holland & Kiehn 1968,
Jacobson et al. 1970). All the assembly intermediates described above can be
demonstrated in an infected cell by sedimentation analysis: the heterotrimeric
protomer (5S), the pentamers (14S), the empty capsid (approximately 75S), and the
encapsidated mature virion (160S).
A single infected cell can typically produce 104 to 105 poliovirus particles, that are
released by lysis of the cell. The lysis has been proposed to occur due to increased
permeability of the cell membranes (Carrasco 1977), which results from increasing
concentrations of nonstructural proteins 3A and 3AB (Lama & Carrasco 1992a,
Lama & Carrasco 1992b), 2 BC (Aldabe et al. 1997), and 2B (Lama & Carrasco
1992b, van Kuppeveld et al. 1997). Recent data suggests that apoptosis might also
be a significant factor in the symptoms that arise from persistent infections of the
central nervous system (Girard et al. 1999), and that poliovirus 3C induces
apoptosis by a caspase-dependent mechanism (Agol et al. 1998, Barco et al. 2000).
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Cellular receptors for enteroviruses
Initiation of viral infection is dependent on attachment to a cellular receptor
molecule. Attachment to these molecules is specific, and during evolution, viruses
have adapted to use a variety of receptors. Several such receptors are known for
various enteroviruses (Table 2). There are several examples of closely related
viruses using different receptors for entry. On the other hand, some evolutionarily
distant viruses can use the same receptor, as shown by the coxsackievirus-
adenovirus receptor (CAR) (Bergelson et al. 1997a). The murine homologue of this
molecule (mCAR) is also capable of functioning as a receptor for both coxsackie-
and adenoviruses (Bergelson et al. 1998). Moreover, there are viruses that have
been shown to use at least two different receptors. An example of such viruses is
CAV9 (Roivainen et al. 1991a, Hughes et al. 1995, Roivainen et al. 1996), the virus
mainly studied in this thesis. In addition to the primary receptor molecules, many if
not all viruses need additional proteins, sometimes called coreceptors, for entry.
CAV21 has been shown to require the presence of both ICAM-1 and the decay-
accelerating factor (DAF) for cell entry (Shafren et al. 1997), and there is a post-
attachment requirement for β2-microglobulin in the entry process of CAV9
(Triantafilou et al. 1999).
When rhinoviruses were found to have a narrow canyon around the fivefold axis,
these canyons were suggested to be the receptor recognition sites (Rossmann et al.
1985). Similar canyons have been found in all entero- and rhinovirus structures
determined to date, and recently, structural studies have unambiguously resolved
the precise location of binding. Structures of HRV14 and HRV16 complexed with
domains of ICAM-1, and PV1 in complex with PVR have verified that the receptor
binding site actually is in the canyon (Olson et al. 1993, Bella et al. 1998, Kolatkar
et al. 1999, Belnap et al. 2000a, He et al. 2000).
There are at least two alternative receptors for CAV9, the integrin αvβ3, which is the
vitronectin receptor (Roivainen et al. 1991a, Roivainen et al. 1994), and an
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unidentified cell surface receptor (Hughes et al. 1995, Roivainen et al. 1996). The
integrin αvβ3 recognizes the tripeptide arginine-glysine-aspartate (RGD), which is a
known recognition signal for integrins (Ruoslahti & Pierschbacher 1986) containing
the αv subunit (Hynes 1992). The RGD sequence is used in some other animal
viruses as a receptor recognition sequence, as exemplified by the echovirus 9 Barty
strain (Zimmermann et al. 1997), FMDV (Fox et al. 1989, Berinstein et al. 1995),
and human parechovirus 1, that was formerly known as echovirus 22 (Stanway et
al. 1994). CAV9 has this tripeptide close to the C terminus of VP1, in a sequence of
approximately 15 amino acids that is not found in other enteroviruses (Chang et al.
1989).
Integrin αvβ3 was found to act as a receptor for CAV9 in GMK cells (Roivainen et
al. 1991a, Roivainen et al. 1994), but proteolytic cleavage (Roivainen et al. 1991a)
and site-directed mutagenesis studies (Hughes et al. 1995) thereafter revealed that
CAV9 lacking the RGD motif can still propagate in GMK cells, although displaying
a small-plaque phenotype. Furthermore, in RD cells, removal of RGD from VP1
apparently had no effect in infectivity (Hughes et al. 1995, Roivainen et al. 1996).
Regardless of the capability of CAV9 to survive in vitro without the RGD motif, all
natural isolates contain this motif (Chang et al. 1992, Santti et al. 2000). These
results show that although CAV9 does use the integrin αvβ3 as a receptor, it can also
use an alternative receptor. This is one of the several examples of viruses that are
not dependent on a single receptor, underlining the assumption that the identity of
the receptor may not be as important for virus survival as has been thought earlier,
although it can still have a role as a determinant of pathogenesis.
Judging by the phenomena described above, it seems that viruses are somewhat
opportunistic in their receptor usage, being capable of adapting to different
receptors during virus-host coevolution. This view is supported by the finding that
there is variation in receptor specificity within a given CBV serotype, depending on
the passaging history and between various isolates (Bergelson et al. 1997b). It has
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also been suggested that the ability to bind DAF may have originated more than
once among enteroviruses (Powell et al. 1999).
Table 2. Current view of enterovirus receptors
Receptor Virus Reference
Immunoglobulin superfamily:
PVR PV1-3 Mendelsohn et al. 1989
 intercellular adhesion molecule 1 (ICAM-1) CAV13, 18, 21 Colonno et al. 1987
CAV15, 20 Pulli et al. 1995
 coxsackievirus-adenovirus receptor (CAR) CBV1-6 Bergelson et al. 1997a
Integrins:
 integrin αvβ3 CAV9 Roivainen et al. 1994
EV9 (Barty) Nelsen-Salz et al. 1999
 integrin α2β1 (VLA-2) EV1 Bergelson et al. 1992
Other:
 decay-accelerating factor (DAF, CD55) CAV13, 18 Colonno et al. 1986, 1987
CAV21 Shafren et al. 1997
CBV3 Bergelson et al. 1995
CBV1, 3, 5 Shafren et al. 1995
EV7 Ward et al. 1994
EV13, 21, 29, 33 Bergelson et al. 1994
EV70 Karnauchow et al. 1996
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Conformational transitions in the capsid
Upon attaching to the receptor, enteroviruses undergo a permanent reorganization of
the capsid, characterized by a shift from a 160S sedimenting particle to a 135S
particle. The 135S particle has lost the majority of the 60 copies of the capsid
protein VP4, and the antigenicity and protease sensitivity are altered in comparison
to the native virion (CBV3: Crowell and Philipson 1971; PV: Fenwick & Wall
1973, De Sena & Mandel 1977). One of the specific alterations is the exposure of
the N terminus of VP1 (Fricks & Hogle 1990). This 135S altered particle (A
particle) is thought to be an essential intermediate in initiating a new infectious
cycle, while being itself noninfectious (PV: Joklik & Darnell 1961, Fenwick &
Cooper 1962, Lonberg-Holm et al. 1975; CBV3: Crowell and Philipson 1971).
Nevertheless, it has been shown that to a very small extent, it is capable of initiating
infection in cells that are nonsusceptible to the intact 160S virion (Curry et al.
1996).
Poliovirus infection can proceed without accumulation of 135S particles, which
could be interpreted as suggestive evidence of its lack of importance. In these
studies, the infection was found to occur in the presence of a capsid-binding drug
R78206 (Ofori-Anyinam et al. 1995), or the virus had been adapted to grow in
HeLa cells at +25 °C (Dove & Racaniello 1997), at which temperature the
conformational transitions do not occur (Yafal et al. 1993). These data are not
conclusive, since the results could be interpreted as showing that one kinetic barrier
has been overcome in the conditions used, resulting in lack of accumulation of the
transformed particles, rather than lack of transformation. Another kind of evidence
was provided by a kinetic experiment in which the amounts of intact poliovirions,
135S particles, and 80S particles were followed during incubation with purified
PVR. In this study, the 80S particles appeared to be transformed from the 160S
particles, but not from the 135S particles (Arita et al. 1998). This seems to suggest
that the accumulating 135S particles are not intermediate forms on the productive
infectious pathway. However, there are several lines of evidence suggesting that the
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135S particles are in fact an intermediate in the infection process. First, the 135S
particle is the dominant virus form found inside the infected cells in the early phase
of infection (Lonberg-Holm et al. 1975, Everaert et al. 1989), but a portion of the
attached virus particles are also eluted from the cells as 135S particles, and can be
purified (PV: Fenwick & Cooper 1962, CBV3: Crowell & Philipson 1971). Second,
the same reorganization of the capsid is seen when incubating polioviruses with
solubilized poliovirus receptor (PVR) (Kaplan et al. 1990), or when incubating
enteroviruses with membrane extracts (CBV3: Roesing et al. 1975; PV: De Sena &
Mandel 1976, 1977; Guttman & Baltimore 1977). Third, several antiviral drugs,
such as arildone (McSharry et al. 1979, Caliguiri et al. 1980) and the WIN
compounds (McKinlay 1985), function by binding to enteroviruses, thereby
hindering the conformational transitions. Fourth, 135S particles bind to lipid
bilayers, forming ion channels (Fricks & Hogle 1990, Tosteson & Chow 1997).
Fifth, the 135S particle is moderately infectious (Curry et al. 1996). Sixth, mutant
polioviruses overcome defects, caused by mutated receptor, by lowering the thermal
energy required for the structural change into 135S particles (Wien et al. 1997).
For the above reasons, the 135S form of the virus particle is generally seen as an
intermediate in the process where the stable virion transforms due to receptor
binding, in order to finally release the genome into the cytoplasm of the susceptible
cell. Empty capsids (VP12360) can be purified from infected cells soon after
initiation of infection, and by releasing the RNA, the particles have shifted from
135S particles to 80S particles.
Enteroviruses can transform into 135S particles without the presence of receptors,
when incubated at elevated temperatures and hypotonic conditions (CAV13: Cords
et al. 1975; PV: Lonberg-Holm et al. 1976, Wetz & Kucinski 1991). The resulting
135S particles are indistinguishable from those appearing during infection. The
receptor therefore functions like an enzyme, by reducing the thermal energy
required in transforming the stable capsid into an entry-competent form (Chow et
23
al. 1997). Conversely, it has been shown that receptor defects can be overcome by
viral mutations that lower the transformation energy (Wien et al. 1997).
Very recent data suggest that there is an intermediate structure in the transition
pathway from 160S native virions to the 135S particles. These 147S particles
contain VP4, they are infectious, and the N terminus of VP1 is apparently not
exposed, as suggested by resistance to V8 protease digestion (Pelletier et al. 2000).
In the conditions used, an alternative form of 135S particles was also detected,
containing VP4.
In addition to the irreversible structural changes that occur in the capsid during
uncoating, virus particles are known to undergo reversible transitions. In contrast to
the static view of the virus particles that is given by the crystallographic studies, it is
known that the capsids are actually flexible and dynamic entities. It has been known
for a long time that polioviruses exist as two interconvertible forms that have
different isoelectric points (pI 7 or 4; Mandel 1971). These two forms might reflect
the apparent controversy observed between the crystal structures and various
biochemical studies; namely, some of the regions that are inside the capsid in the
crystal structures, are actually reachable by antibodies. The regions that have been
shown to be involved in reversible exposure are the internal capsid protein VP4 (Li
et al. 1994) and the N terminus of VP1 (Chow et al. 1985, Roivainen et al. 1993, Li
et al. 1994).
The N termini of enterovirus VP1 proteins are very heterogeneous both in length
and sequence, but there is a highly conserved region close to the N terminus of VP1
of all enteroviruses (Hovi & Roivainen 1993). This motif was first identified as a
part of an immunodominant region of 20 amino acids (Roivainen et al. 1991b). As
it was noticed that the immunogenicity was combined with a conserved sequence, it
was shown that antibodies against this sequence can be used as a group reagent
recognizing enteroviruses (Hovi & Roivainen 1993). Peptide antibodies against this
motif (amino acids 42-52 in PV1/Mahoney) were shown to be capable of
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precipitating purified poliovirus particles, showing that this region is exposed in
solution (Roivainen et al. 1993), while being on the inner surface of the capsid in
the crystal structure. It was also conclusively shown that the neighboring region,
amino acids 24 to 40 of VP1 of PV1/Mahoney is transiently exposed (Li et al.
1994), by demonstrating that antibody recognition of this motif is dependent on
coincubation of the virus and the antibodies at +37 °C. The transitions are thus
reversible, occurring at physiological temperatures but not below that (Li et al.
1994). On the other hand, it has been shown that poliovirus can be
immunoprecipitated at room temperature by overnight incubation with peptide
antibodies against amino acids 42-52 (Roivainen, unpublished results). These
apparently contrasting observations could be explained by a kinetic equilibrium of
the two forms of the virion. The transiently exposed portions could bind to
antibodies with kinetics determined by the incubation temperature, and then being
locked in this conformation by the antibody.
Medium-resolution structures of the 135S and 80S particles (2.2 nm resolution)
were recently revealed using cryo-electron microscopy and image reconstruction
(Belnap et al. 2000b). The structures indicate that both 135S and 80S particles are
approximately 4 % larger than the virion, therefore having thinner, as well as more
angular capsids. They also indicate domain movements of up to 0.9 nm (3 % of the
virion diameter), and gaps that are seen as plausible sites for the externalization of
the VP4 and the N terminus of VP1. Other studies have suggested that VP4 and the
N terminus of VP1 would exit through the fivefold axis (Hadfield et al. 1997,
Hendry et al. 1999), or that VP4 would exit through a channel along the fivefold
axis and the N terminus of VP1 through the pseudo threefold axis (Lentz et al.
1997). However, it was suggested that the exit site for both of these would be the
base of the canyon, and the five extended N terminal arms of VP1 would follow the
fivefold protrusion on the surface of the capsid, meeting each others at the fivefold
axis, ideally positioned for membrane insertion (Belnap et al. 2000b). The fivefold
vertex was not favored as the exit site for VP4 and the N termini of VP1, as there is
a plug formed by the N termini of VP3 that is present in both 160S and 135S
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particles, seeming to prevent the use of this location as the exit site. It was
suggested that despite the VP3 plug, the RNA could be released through the
fivefold axis, as the plug might act as a float-valve (Belnap et al. 2000b).
Interactions of enteroviruses with lipid bilayers
Poliovirus 135S particles are capable of attaching to liposomes, artificial lipid
bilayers (Lonberg-Holm et al. 1976), and this attachment is dependent on the
exposed N terminus of VP1 (Fricks & Hogle 1990). On the other hand, poliovirus
infection is known to permeabilize the infected cell to various compounds
(Fernández-Puentes & Carrasco 1980). These observations have led to the view that
as the infection of the cell is initiated, the enteroviruses form a pore on one of the
cellular membranes (Fricks & Hogle 1990). The pore is believed to be composed of
at least the five N termini of VP1 that are present near the pentamer fivefold axis,
and the myristate-linked VP4 is also very likely to be involved (Moscufo et al.
1993). It is possible that the receptor or some other cellular compound is also
involved.
Earlier it was thought that the conformational transition to the 135S particle is
required before binding to the membrane can occur, but recently it was shown that
also native poliovirus is capable of binding to a planar lipid membrane (Tosteson &
Chow 1997). Furthermore, both 135S and 160S particles induce the formation of
ion-permeable channels in such membranes (Tosteson & Chow 1997). This finding
is in line with the observation that poliovirus infection changes the permeability of
infected cells (Fernández-Puentes & Carrasco 1980), although the change in
permeability allows entry of larger molecules than could be explained by these
channels. The infected cells are permeabilized to compounds like luciferase,
horseradish peroxidase (Otero & Carrasco 1987), and polysaccharides (Gonzáles &
Carrasco 1987). The channels formed by the two forms of poliovirus were found to
be different in nature, the ones formed by the 135S particle being larger and
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independent of temperature or voltage across the membrane. It can therefore be
speculated that the two forms of channel either have a different function in the
infection process, or that one (or both) of them has no role in it. Uncoating of
poliovirus appears to be necessary for the permeabilization of infected cells, since
uncoating inhibitors also block membrane permeabilization (Almela et al. 1991).
Based on the observed conductance of the channels, it was estimated that the
channel formed by the 135S particle should have a diameter of approximately 2 nm,
which could in theory allow the RNA genome to pass through (Tosteson & Chow
1997). The diameter of a fully extended RNA molecule is approximately 1 nm. This
data is consistent with the model that enterovirus capsid proteins would form a pore
in one of the cellular membranes, allowing the RNA genome to enter the cytoplasm
either through a pore or by lysis of an endosome. While the channels formed by the
135S particles might be an essential step in enterovirus infection cycle, it is unclear
whether the channels induced by the native virions can be associated with the
normal infection process, or whether they merely reflect properties of the virion that
are necessary for the uncoating to occur.
It can also be speculated that the channels as such would not have a function in the
normal infection, but that they are merely an artificial effect demonstrating the
physical properties of the viral particles. Permeabilization of the newly infected cell
is a specific phenomenon and does not occur in nonsusceptible cells (Otero &
Carrasco 1987, Carrasco 1995). This would suggest that the virus binding and
channel formation phenomena that occur nonspecifically in liposomes and other
artificial membranes, do not necessarily occur similarly in a normal infection.
Specifically, when the 135S particles are studied, they have already lost the
majority of the VP4 protein that is needed in the cell entry (Moscufo et al. 1993),
and may be important in the functional channel formation during this process.
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Entry route
The productive infectious pathway of enteroviruses is ill-understood between
attachment to a cell surface receptor and initiation of replication in the cytoplasm. It
is known that both the 135S particles and even native virions can be internalized
into the cell under appropriate conditions (Fenwick & Wall 1973, Lonberg-Holm et
al. 1975, Willingmann et al. 1989, Kronenberger et al. 1992, Kronenberger et al.
1998). A major problem in trying to elucidate the infectious pathway is the very
large particle/infectious unit ratio of all enteroviruses. Only one virus particle out of
100 or more actually initiates an infectious cycle, while all direct chasing methods
follow the bulk of the virus population. It is therefore clear that any straightforward
observation concerning the fate of the virus or its subunits is unavoidably clouded
and potentially misled by the bulk of the virus population engaged in apparently
futile events.
In order for the infection to be initiated, the viral genome must pass at least two
obstacles: the stable virus capsid and a cellular membrane. The suggested models of
infection propose three locations as the site of crossing the protein-membrane
barrier between the viral RNA and cellular cytoplasm. Direct penetration through
the plasma membrane was suggested when electron microscopic images showed
apparently intact poliovirus particles in the cytoplasm 3 min after infection
(Dunnebacke et al. 1969). The endocytic pathway was also supported by electron
microscopy, since poliovirus particles were found in endocytic vesicles (Dales
1973). Most recently, EV1 was found to co-localize with caveolin-1 but not with
markers of the clathrin endocytic pathway, suggesting caveoli as the entry site for
this virus (Marjomäki et al. 2000). It has also been proposed that polioviruses are
not dependent on a single infectious pathway and that several alternative pathways
could exist together (Arita et al. 1998, Arita et al. 1999).
Numerous experimental setups have been used in order to find out whether
acidification, that occurs in the clathrin-coated pits pathway, is necessary for the
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infection to occur. Some of the earlier results suggested that acidification of
endosomes is needed for poliovirus infection (Madshus et al. 1984a, Madshus et al.
1984b), but increasing evidence argues the contrary (Gromeier & Wetz 1990, Pérez
& Carrasco 1993, DeTulleo & Kirchhausen 1998).
Acidification appeared to be necessary when studying poliovirus infection with
compounds that either dissipate proton gradients across membranes, or inhibit the
acidification process of endosomes (Madshus et al. 1984a, Madshus et al. 1984b).
These studies showed that both these types of compounds inhibited infection, and
the inhibition was overcome by exposing the cells to low pH. Nevertheless, another
study showed that use of these compounds resulted in a delay in infection, but not
inhibition (Gromeier & Wetz 1990). The delay was due to side effects of these
compounds (Cassell et al. 1984), and not the pH-elevating mechanism (Gromeier &
Wetz 1990).
Bafilomycin A (BFLA) is an inhibitor of vacuolar proton-ATPases, enzymes that
acidify endosomes as well as other vesicular organelles (Bowman et al. 1988). This
drug has also been shown to have unwanted effects: it blocks endosomal transport
in a cell line-dependent manner (Bayer et al. 1998). Therefore, inhibition of
infection in the presence of BFLA does not necessarily imply that the virus is
dependent on acidification, but a negative effect on inhibition apparently shows that
the studied virus does not require acidification for infection. It has been shown that
BFLA does not affect infection by poliovirus (Pérez & Carrasco 1993) or CAV9
(Roivainen, unpublished results), and these viruses therefore do not require an
acidic environment for entry.
Further evidence against the necessity of using the clathrin endocytic pathway was
obtained by using HeLa cell lines that expressed either dynaminK44A, failing to load
GTP, or dynamints, failing to hydrolyze GTP at the non-permissive temperature
(DeTulleo & Kirchhausen 1998). The phenotype of these cells appeared unaltered,
except for the block in the formation of clathrin-coated pits and vesicles. Clathrin-
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dependent endocytosis is blocked in these cells, because dynamin functions in a
GTP-dependent manner in the budding of a clathrin-coated pit. The results showed
that poliovirus 1/Mahoney was able to infect the cells in a clathrin-independent
manner, while the three other viruses studied were not. Two of these viruses had
envelopes (Semliki Forest virus and Sindbis virus), but even human rhinovirus 14,
an unenveloped picornavirus, appeared to be dependent on the clathrin-coated
vesicle formation.
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AIMS OF THE STUDY
The intriguing properties of the conserved PALTAVETGHT motif (described above
in “Conformational transitions in the capsid”) prompted us to study the nature of
this amino acid sequence, and the functions that it might have in the coxsackievirus
A9 infectious cycle. By using a site-saturation approach, we expected to be able to
elucidate both the nature of conservation that is seen in the amino acid sequences,
and to probe the function that the motif was hypothesized to have. It was hoped that
the mutants would assist in understanding the reversible and irreversible
conformational transitions that occur in the enterovirus structure. To reach this goal,
we wanted to develop a new site-saturation strategy to be used in studying
picornaviruses. The results obtained during the work prompted us to ask whether
the liposome-binding properties of poliovirus are a common feature of
enteroviruses.
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MATERIALS AND METHODS
Numerous laboratory methods have been used in the studies described in this thesis.
The majority of these methods (virus culturing and labeling, analysis of protein
compositions and molar ratios, ultracentrifugations, polymerase chain reactions,
DNA sequencing, etc.) are standard laboratory practices that are described in the
original articles and manuscripts (I-IV), or can be found in laboratory manuals and
textbooks. Only the techniques that are not normally used in virological
laboratories, or contain a novel aspect, are described here.
Viruses and cell lines
Coxsackievirus A9 (Griggs) was obtained as an infectious cDNA clone from Dr.
Glyn Stanway (University of Essex, UK) (Chang et al. 1989, Hughes et al. 1995).
This cDNA was linearized and transcribed to RNA, that was then transfected to
LLC Mk2 cells. The cells were covered by 0.5 % carboxymethylcellulose (CMC),
and well isolated virus plaques were used in growing the virus stocks.
In addition, we used the following viruses, originally obtained from the ATCC:
poliovirus 1/Mahoney, poliovirus 3/Sabin, coxsackievirus A7 (USSR AB-IV),
coxsackievirus A16 (G-10), coxsackievirus A21 (Kuykendall), coxsackievirus B5
(Faulkner), and enterovirus 68 (Fermon).
In propagating the viruses, we used green monkey kidney cell lines (LLC Mk2,
GMK, Vero) and human tumor-derived cell lines (HeLa-Ohio, RD, HEp-2c).
Vectors and primers
The M13mp18 vector and the E. coli TG1 strain were obtained in the Sculptor In
vitro Mutagenesis Kit (Amersham, UK). Vector pBS was obtained together with the
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Table 3. Oligonucleotides used in this thesis.
Oligo Sequence (5’-3’) Use (ref.) CAV9 position
I CAATTCCGCGAGCGTAXYZGCACTCACTGCAGTTG m (I) 2516-2550
II GCACTCACTGCAGTTXYZACAGGGCACACCTCG m (I) 2535-2567
III GTACCTGCACTCACTXYZGTTGAGACAGGGCAC m (I) 2529-2561
IV GTTGAGACAGGGCACXYZTCGCAAGTTACTCCAAG m (I) 2547-2581
V CCGCGAGCGTACCTXYZCTCACTGCAGTTGAG m (I) 2521-2552
VI GCGAGCGTACCTGCAXYZACTGCAGTTGAGACAG m (I) 2523-2556
VII GCGTACCTGCACTCXYZGCAGTTGAGACAGGG m (I) 2527-2558
VIII CCTGCACTCACTGCAXYZGAGACAGGGCACAC m (I) 2532-2563
A1 CTAGACGTACGGCGCGCT a (I) -
A2 CTAGAGCGCGCCGTACGT a (I) -
7625 GCGTGCAACGACTTCTCAGTAAGAATGTTGAG p, s (II, III) 2379-2410
4934 CACAGTCGACTCAGATCTAGAATGATAGTTTTTCAC p, s (II) 2639-2604
M13 –40 GTTTTCCCAGTCACGAC s (II) -
3869 TAATAAGCTTCAAGGGGAT m (II) 2435-2453
6093  GACATGTGAAAAACTATCATTCTAGATCTGAGTCGACTGTGGAG m (II) 2599-2642
6966 CTATCATTCTAGAAGTGAGTCGACTGTGG m (II) 2612-2640
91856 CGGTGAGCAACAGAGCTATTGTGTATCTGTTTACTG p, s (III) 641-676
91857 CCATCTCAGCCTCGGGCACACACAC p, s (III) 1347-1323
92066 CAGAACATGCAATACCACTACCTGGGTCGTGCAG p, s (III) 1230-1263
92067 CACGACCGAGTCCACTTCTGCTATTTCCATTAG p, s (III) 1892-1860
91860 GGCCTTTGCCACAATTTGATGTGACGCCT p, s (III) 1801-1829
91861 CAACTGCCCTCTCAATGGCTTCTTCCACAT p, s (III) 2481-2451
9354 CACCCGTCATAAAAATTGCTGTATGCATTTCC p, s (III) 3043-3012
91862 GATTCCAGCAAAAGTTGATGATTATGCCTGGCAG p, s (III) 2903-2946
91863 CAATTTTGCCAATCCGTGTGTGTTG p, s (III) 3436-3408
Primers are given with the names or numbers used in the original articles. Code: a, used in
forming an adapter; m, used in mutagenesis; p, used in PCR; s, used in sequencing. If the
oligonucleotide was used in mutagenesis, the mutagenic bases are underlined. Numbering
of the nucleotide positions is according to Chang et al. (1989). In oligonucleotides I and II,
the bases X, Y and Z each contained 25 % of A, C, G, and T. In oligonucleotides III-VIII,
the proportions of bases were modified as described in article I.
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CAV9 clone from from Dr. Glyn Stanway (University of Essex, UK).
Oligonucleotides were synthesized in the National Public Health Institute (Helsinki,
Finland), or at the Institute of Biotechnology (University of Helsinki, Finland).
Primers used in mutagenesis, polymerase chain reactions, sequencing, and in
creating an adapter, are shown in Table 3.
Cloning and site-saturation mutagenesis (I, II)
Nucleotides 1661 to 2982 (1322 bp) of the CAV9 genome in pBS vector were
cleaved from the cDNA clone (Chang et al. 1989, Hughes et al. 1995) by restriction
endonucleases BsiWI and BssHII, and ligated to an M13mp18 vector supplemented
with additional cleavage sites for these enzymes, created by using an adapter. Site-
directed (silent) mutagenesis was performed (see below) to introduce unique
restriction sites for XbaI and HindIII, and the 1322 base pairs were cloned back into
the genome. The silent mutations were G2444T, G2621T, C2622A, C2624A,
T2625A, and C2626G. These mutations facilitated the cleavage of a fragment of
180 nt around the target area without changing the amino acids coded therein. This
fragment was subcloned from the pBS/CAV9 plasmid into M13mp18 as above, and
site-saturation mutagenesis was performed on four different codons.
Site-saturation mutagenesis was performed, using the single-stranded form of
M13mp18 including the 180 bp CAV9 insert, by primer extension reaction with
degenerate central trinucleotides in the oligonucleotides, using the Sculptor In vitro
Mutagenesis Kit (Amersham, UK) with the E. coli TG1 strain included in the kit.
The method is a modification of the original M13-based phosphorothioate technique
(Sayers et al. 1992). Annealing of the mutagenic oligonucleotide to the single-
stranded template DNA was performed by first incubating the annealing mix for 3
min at +80 °C, then moving the mix to a waterbath at +60 °C, and allowing the
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waterbath to cool to +37 °C during 60 min. The primer extension reaction was
performed using T7 DNA polymerase with a dNTP mix with three normal bases
and the dCTP base analogue dCTPαS, in the presence of T4 DNA ligase. The
phosphorothioate base has a sulphur atom substituted for oxygen at the alpha
phosphate. Remaining single-stranded DNA was digested by T5 exonuclease. The
non-mutant strand was nicked by the restriction endonuclease NciI (recognition
sites: CCCGG or CCGGG), which does not cleave the phosphorothioate
internucleotidic linkages, therefore leaving the mutated strand intact. The nicked
non-mutant strand was partially digested using exonuclease III, and repolymerized
by DNA polymerase I to include the mutated area. Ligation was again accomplished
by T4 ligase. E. coli TG1 bacteria were transformed with the mutated DNA, and
grown on petri plates containing a culture of E. coli TG1 to facilitate multiplication
of the M13mp18 bacteriophage.
The M13mp18 phage plaques were transferred from culture plates by allowing the
plaques to attach to a Magna Lift nylon membrane (Micron Separations) at +37 °C,
that was then lifted to an Erlenmeyer flask with 2 x TY medium containing E. coli
TG1. The flask was agitated vigorously at +37 °C for 4 h 40 min, after which
double-stranded M13mp18 DNA was purified from the bacteria using the Qiagen
Midi Plasmid kit. The 180 bp fragment was cut by XbaI and HindIII, purified from
agarose gel, and ligated back to CAV9 cDNA. The cDNA pool was transfected to
E. coli, and bacterial colonies were replica-plated as the M13 plaques above. The
bacterial colonies on the nylon membrane were lifted to LB medium containing 100
µg/ml ampicillin, and allowed to grow overnight with vigorous agitation. The
plasmid DNA was purified with the Qiagen Midi Plasmid kit.
Figure 4. Site-saturation mutagenesis and cloning scheme.
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This plasmid pool, now containing the infectious CAV9 clone with all possible
codons at one selected amino acid-coding position, was linearized by cleaving with
restriction endonuclease ClaI. Infectious viral RNA was synthesized by T7 RNA
polymerase, and transfected into LLC Mk2 cells by Lipofectin (Gibco-BRL).
Lipofectin was replaced by medium containing 0.5 % CMC and 10 % fetal calf
serum, and the plates were incubated at +37 °C for 1 to 3 days, picking the plaques
in 2 µl of medium upon their appearance. These virus samples were plaque-purified
once, and the resulting plaques were propagated on 6-well plates until full CPE was
seen. Success of site-saturation was confirmed by sequencing. The complete
cloning scheme is shown in Figure 4.
Liposome flotation (IV)
Lipid stocks were prepared from phosphatidylethanolamine, phosphatidylcholine,
sphingomyelin, cholesterol, and phosphatidic acid in molar ratios of 1:1:1:1.5:0.3
(White & Helenius 1980, Fricks & Hogle 1990). In each experiment, 1 µmol of
total lipid was used. Liposomes were prepared by dispersing dried lipids in buffer
containing 10 mM sodium phosphate, 140 mM NaCl, 1 mM CaCl2, 1 mM MgCl2,
and 0.1 % bovine serum albumin, warmed to +50 °C, vortexed for 1 min, and
sonicated for 1 min at +50 °C.
Virus particles were mixed with liposomes at room temperature, and incubated for 5
min at various temperatures between room temperature and +50 °C. The mixture
was brought back to room temperature and mixed with 67 % sucrose to obtain 50 %
final sucrose. This sample layer was overlaid with two layers of 25 % and 10 %
sucrose, respectively. These step gradients were centrifuged for 16 hours at 40 000
rpm at +18 °C, and the gradients were fractionated. Sample radioactivity was
measured in a Wallac MicroBeta counter (Wallac, Finland), using 50 µl samples
and 200 µl Optiphase Supermix SC/9235/21 scintillation liquid (Wallac, Finland).
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RESULTS AND DISCUSSION
Site-saturation (I)
Site-saturation mutagenesis is a method that is used in replacing a selected codon by
a set of codons that, upon translation, should yield all 20 amino acids in the mutant
population. We decided to use this method in order to estimate what phenotypic
features of the studied motif (see the next chapter) are associated with its
evolutionary conservation, and to probe the function that the motif might have.
When performing the site-saturation mutagenesis in an M13 system, we noticed that
the previously used methods did not yield a random set of codons. Instead, the
individual positions of the resulting set of codons at the target position were found
to have a strong bias, tending to conserve the original sequence. Percentages of
original bases were between 35 % and 58 %, rather than the expected 25 %. We
concluded that this is due to the differential melting temperatures (Tm) of the
mutagenic degenerate oligonucleotides, and decided to study whether this bias
could be corrected by modifying the nucleoside phosphoramidite compositions
during the synthesis of the mutagenic oligonucleotides. Our aim was to find out
whether there were some general rules that could be applied in correcting the
compositions.
We synthesized six degenerate oligonucleotides, now with modified base
compositions, and used them in site-saturation mutagenesis of six codons. In the
degenerate positions of the mutagenic oligonucleotides, we reduced to varying
extents the complementary bases, in favor of the mutagenic bases. We studied a
total of 344 mutagenized codons, and made a statistical analysis of the results, in
order to find out the underlying general rules that could be applied in further
studies. We analyzed the effects of the various base compositions at the nucleotide
and the codon level, the influence of the mismatching positions, and the possible
significance of all non-Watson-Crick base pairs.
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The oligonucleotides with modified compositions yielded an almost optimal
randomization in the resulting codons. There was a drawback, however, that needed
to be considered separately: the central position (p2) of the codon was too heavily
balanced towards mutagenesis. This was presumably due to the lack of base pair
stacking in the cases when the annealing mutagenic oligonucleotide has mismatches
at both the first and the third positions (p1, p3) of the codon. In these cases, the
central matching nucleotide contributes very little thermodynamic stability, and
therefore, in the subset of mutagenic oligonucleotides having p1 and p3 mutated,
the identity of p2 reflects the base composition of the mutagenic oligonucleotide at
that position. In the analysis of all double mutants found in the study, p1 and p2
were mutated in 54 codons, p2 and p3 in 57 codons, but p1 and p3 in only 24
codons.
In addition to the differential stabilities of the normal Watson-Crick base pairing
(C-G being stronger than A-T), the non-Watson-Crick base pairs are known to have
differences in their stabilities (Werntges et al. 1986). We analyzed whether the
effect of these differences could be seen in the set of mutagenized codons. Although
there was some overrepresentation of the 2nd and 3rd strongest pairs G.G and A.G
(Aboul-ela et al. 1985), and underrepresentation of the weakest base pair C.C, the
results led us to conclude that non-Watson-Crick base pairing does not need to be
considered in designing the oligonucleotides for site-saturation mutagenesis.
Based on the analysis of the data set, we proposed a general design for the
degenerate positions in the mutagenic oligonucleotide. In this design, the
differential stabilities of the two Watson-Crick base pairs, as well as the special
nature of the central base pair have been considered (Table 3 in I).
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The VP1 intracapsid hook (II, III)
In all enteroviruses, there is a highly conserved amino acid motif of 11 residues
close to the N terminus of VP1 (II). The consensus sequence of this motif is
PALTAVETGHT. In an alignment of 79 different enterovirus sequences of 68
different serotypes, five of the 11 amino acids were completely conserved
(underlined residues above), and there were no insertions or gaps in this motif (II).
The amino acids taking part in the β-barrel formation are known to be highly
conserved among enteroviruses, while the loop regions between the β-strands and at
the N and C termini of the proteins are more variable. Outside of the β-barrel-
motivated conservation, the PALTAVETGHT region appears to be the most
conserved region in the viral structural proteins.
This region has been shown to be transiently exposed in native poliovirus virions
(Roivainen et al. 1993, Li et al. 1994), although being inside the capsid in the
crystal structure. These properties of the conserved motif lead us to use site-
saturation mutagenesis in order to probe the nature of the conservation, and to make
an attempt to elucidate the functions that this motif might have in the enterovirus
life cycle. To facilitate the site-saturation mutagenesis, we made several
improvements to the previously used methods, allowing the transfection of a site-
saturated viral genome pool (II). This “single-tube” site-saturation method should
be useful in studying any virus, provided that the viral genome is cloned and the
cDNA, or its derivatives, are infectious in cell culture.
When studying the structures of the six enteroviruses that have been published, we
found that this region is always in exactly the same position (III). Furthermore,
exactly the same organization is seen in rhinoviruses (III). The β-barrel of the VP1
protein is separate from the N terminal 60 to 80 residues, the β-barrels of five
copies of VP1 forming the protrusion at the fivefold axis, and the 'north' rim of the
canyon. On the N terminal side of the β-barrel, the chain first dives to the inner
surface of the capsid, and there forms a long loop of approximately 45 to 50 amino
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acids. The very N terminus then forms an extended arm towards the fivefold axis
(Figure 7 in III). The loop region makes a tour on the inner surface of the capsid,
with approximately 20 amino acids forming a hook-like structure at the end of the
loop. In this hook, the PALTAVETGHT motif is covered in a cavity formed by the
other three capsid proteins.
When viewed from within the capsid, the bottom of the hook cavity is formed by
the BIDG β-sheet of VP3, the tip is formed by VP2, and the hook is loosely covered
by the approximately 16 C terminal residues of VP4. When studying the contacts
that the hook amino acid residues have with the neighboring capsid proteins, we
found that there are completely conserved contacts with all the other capsid proteins
(III). In particular, the tripeptide Gln-Ser-Ser (QSS) in VP3 was found to be
identical in all enterovirus structures, and always in contact with leucine (L) and
glutamate (E) of the PALTAVETGHT motif (III). The same organization is seen in
rhinoviruses, except that the latter serine of the QSS motif is replaced by threonine.
We performed oligonucleotide-mediated site-saturation mutagenesis of four codons
in the hook. When trying to mutate the CAV9 residues A30, L31, T32 and V34
(PALTAVETGHT), we were unable to recover a viable virus carrying a mutation at
the leucine residue L31 (II). This was not due to a problem in the site-saturation
method, since we could recover mutant viruses with three different leucine codons
at the target location (II). It was not surprising that this amino acid does not seem to
allow variation, as it was the only completely conserved residue of the ones that we
tried to mutate. It is also the residue that is always found in contact with the QSS
motif of VP3.
At the other mutated positions, we found a number of various substitutive amino
acids among the viruses recovered (II). Alanine 30 allows clearly more variation
than the other amino acids, and we recovered viruses carrying both polar
(glutamine) and nonpolar substitutions (cysteine, leucine), in addition to
intermediate ones (asparagine, glycine, serine, and the wild-type alanine). At
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position 32, we found two substitutions of intermediate polarity (histidine and
serine), in addition to the wild-type threonine, which is polar. At position 34, we
found two intermediate-polarity substitutions (alanine and serine), and three
nonpolar residues (cysteine, isoleucine, and the wild-type valine). In other words,
the intermediate-polarity alanine could be mutated to both polar and nonpolar amino
acids, the polar threonine could be changed to intermediate polarity (but not
nonpolar), and the nonpolar valine could be changed to intermediate polarity (but
not polar). The variation in the viable mutant viruses faithfully follows the variation
that is observed among enteroviruses (Table 2 in II), strongly suggesting that it is
the polarity in the region around the five completely conserved amino acids, that
needs to be conserved (II).
The hook region of the VP1 of CAV9, at positions 28 to 51, has a clearly periodic
hydrophobicity profile, characteristic of amphipathic structures (II). The
conservation of this profile and the finding that site-saturation did not yield any
mutant viruses in which a polar amino acid would be replaced by a nonpolar one, or
vice versa, suggests that the studied motif may have a function where amphipathic
nature is needed. No apparent explanation for the conservation of periodic
hydrophobicity could be found by studying the virus structures. The polar and
nonpolar amino acids group together as always, but there is no apparent reason for
periodicity, or even conservation. The recently published model of the 135S particle
(Belnap et al. 2000b) offers an attractive explanation. Namely, it is suggested that
the N termini of the VP1 proteins are externalized through the base of the canyon,
necessitating the release of the pocket factor from the bottom of the canyon. The N
termini of VP1 molecules would then form extended arms towards the fivefold axis,
where the N termini meet and probably form a five-stranded structure that is
inserted into the cell membrane (Belnap et al. 2000b). The arm should therefore be
on the outside of the virus capsid, snaking up the fivefold protrusion, and probably
making a contact with the membrane. This would explain why the potential for
amphipathicity of this region needs to be conserved.
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From the site-saturated virus pools, we purified 12 different mutants, all of which
had defects in producing infectious progeny virus (II). Based on preliminary results
of all viable mutant phenotypes, five mutants were selected for detailed
characterization. The selection was based on three criteria: (i) apparently
homogeneous stocks of the selected viruses could be grown, (ii) all three
successfully mutated positions were represented, and (iii) judging by the initial
characterization, the selected viruses represented a maximal range of phenotypes.
We found two general properties that were altered in the mutant viruses: the
capability to produce infectious progeny virus was decreased, and the
particle/infectious unit ratio was increased (III). In addition, three variables in the
virus life cycle were altered. First, the stability of the virions was changed, two of
the mutants being hyperlabile (A30G and V34A), two being moderately more labile
than the wild-type (A30S and V34I), and one mutant being more stable than the
wild-type (T32S). Second, attachment efficiency to LLC Mk2 cells was significantly
lower for at least two mutants (A30G and V34A). Third, formation of subviral
particles upon attaching to the host cell was altered, and correlated with the stability
of each mutant. We were unable to find any differences in the time scale of
infection, efficiency of protein synthesis, accumulation of assembly intermediates,
release from cells, or sedimentation coefficients of the virions.
All the differences found between the mutant viruses and the wild-type virus can be
explained by variables related to uncoating (III). The hyperlabile mutants were
apparently too easily triggered to transform into A particles, rendering a large
proportion of the viruses unable to initiate infection. This would be the direct reason
for increased particle/infectious unit ratio as well. It can also offer an explanation
for the defects in cell attachment, as the A particles do not attach to cells. It should
be noted that the protein production was not hindered when using similar titers of
input virus, suggesting that production of progeny virus was perhaps not altered, but
the progeny was inactivated too easily. Properties of the moderately labilized
mutants can be explained with same arguments. The stabilized mutant, on the other
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hand, is apparently less sensitive to signals that trigger uncoating, therefore being
ineffective in initiating infection.
The mere location of the PALTAVETGHT motif in the sequence, being close to the
N terminus of VP1, suggests a function involved in uncoating or cell entry, due to
the membrane-binding properties of the N terminus, and its suggested role in
channel formation (Fricks & Hogle 1990). The periodicity in the hydrophobic
profile suggests a function related to membrane interactions (see above), and
properties of the viable mutants suggest that the high degree of conservation may be
needed due to the conserved contacts between residues of this motif and all other
capsid proteins (III). These contacts may, in part, determine the kinetic equilibrium
between the two interconvertible forms of the virus.
Liposome interactions (IV)
Liposome binding of PV1 has been demonstrated earlier (Fricks & Hogle 1990,
Tosteson & Chow 1997), and based on sequence analysis, it has been suggested to
be common to enteroviruses (Fricks & Hogle 1990). Since the binding is dependent
on the N terminus of VP1, and the motif that we have studied is close to this region,
we decided to study whether the liposome binding properties of the CAV9 mutants
would be altered. To our surprise, we were unable to find liposome-associated virus
in these experiments. This prompted us to ask whether liposome binding is a
property that is common to enteroviruses.
We used the liposome flotation method in assaying the binding (White & Helenius
1980, Fricks & Hogle 1990). The studied virus particles were incubated with
liposomes under various conditions, and mixed with sucrose to obtain 50 % final
sucrose concentration (W/V). On top of this sample layer, we carefully added two
layers of more diluted sucrose (25 % and 10 %), and this step gradient was
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ultracentrifugated. During ultracentrifugation, virus particles that are bound to
liposomes, are expected to elevate towards the top of the step gradient.
We characterized the liposome binding of eight enteroviruses, representing all five
enterovirus species (PV and HEV-A to HEV-D). The differences in binding were
found to be remarkably clear. Representatives of the genetic cluster formed by
polioviruses and HEV-C readily bound to liposomes, whereas members of the
HEV-A, HEV-B, and HEV-D species showed only marginal binding under all
conditions used. The binding capacity was not altered by different pH conditions, or
by introducing a pH gradient across the liposome membrane, and the percentage of
attached virus did not increase after five minutes.
We studied the binding of both 135S particles and native virions, and found that the
135S particles bound at +22 °C, while the native virions bound at +37 °C and
temperatures above that. Temperatures between +22 °C and +37 °C were not
studied. At elevated temperatures (+50 °C and above), a minority of the non-
binding viruses were found to form a peak in the flotation pattern, similar to the
ones formed by polioviruses and CAV21. A surprising difference between the
liposome-binding viruses was that while PV1 and CAV21 bound as both 135S
particles and native virions, PV3 bound only as a native virion. Furthermore, the
flotation pattern of PV3 was remarkably different from that of PV1 and CAV21, the
majority of PV3 particles being only slightly elevated. A possible interpretation of
these observations would be that PV1 and CAV21 formed networks through virus
particles that are bound to two or more liposomes, whereas the majority of PV3
would be bound to a single liposome. Another explanation would be that a small
amount of lipids becomes associated with degraded PV3 particles or viral protein
aggregates, forming the slowly elevating material. The latter option seems unlikely,
since this peak was formed by native virions and liposomes, but not by 135S
particles and liposomes.
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Under the conditions used, it seems that out of the eight enteroviruses studied, only
polioviruses and CAV21 are capable of binding to liposomes. There are, however,
two observations that oppose this interpretation. First, at elevated temperatures, the
non-binding viruses did show signs of binding to liposomes. Second, sequence
alignments of the N terminal regions of the viruses show that they all have a
theoretical capacity to be arranged into an amphipathic structure, albeit they share
little or no homology at the level of amino acid identity. The variation in liposome
binding is likely to reflect functional differences in uncoating and cell entry
between the different enterovirus species.
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CONCLUSIONS
The biological properties of two elements in the VP1 protein of enteroviruses have
been studied. One of the elements was a highly conserved amino acid motif of 11
residues (PALTAVETGHT) that lies inside the capsid, but is known to be
transiently exposed. The other element was the N terminus of the same protein,
known to be capable of interactions with lipid membranes.
Four codons corresponding to residues Ala30, Leu31, Thr32, and Val34 of
coxsackievirus A9 capsid protein VP1 were randomized and cloned back to the
infectious cDNA, yielding a pool of genomes that were then transcribed to RNA
and transfected to green monkey kidney cells (LLC Mk2). The spectrum of viable
mutant viruses suggests that the periodic hydrophobicity pattern is required for
viability of the virus. It appears that changes of Thr32 or Val34 to amino acids of
opposite polarity abolished the viability of the virus, but even mutations that
retained the polarity were defective in producing infectious progeny virus. All
mutations affected formation of the A particles, a structurally altered form of virus
that is thought to be an essential intermediate in cell entry. Two mutations strongly
enhanced A particle formation, two others enhanced it to a moderate degree, and
one mutant appeared more stable than the wild-type virus. By structural
comparisons of all entero- and rhinovirus structures available, completely conserved
Van der Waals contacts of the studied motif with all other capsid proteins were
identified.
It is concluded that the PALTAVETGHT motif is one of the key factors that affect
the uncoating process. The motif is suggested to have a kinetic equilibrium between
two states, one being exposed on the surface of the capsid, and the other lying at the
highly conserved pocket formed by the three other capsid proteins. Receptor
binding, or the presence of a membrane, may shift the equilibrium, triggering the
irreversible changes that initiate uncoating through externalization of the N terminal
region of VP1 and the internal capsid protein VP4. Five copies of the very N
47
terminus of VP1 are thought to form a channel through the membrane at the
fivefold axis of the virus, while the PALTAVETGHT is suggested to form an
amphipathic arm between the membrane-spanning N terminus and its exit site at the
base of the canyon surrounding the fivefold axis.
The liposome binding properties of eight enterovirus serotypes were characterized,
using representatives of all five human enterovirus species. The readily binding
viruses were found in the genetic cluster that includes polioviruses and the human
enterovirus C species. Human enteroviruses A, B, and D were found inefficient in
binding to liposomes, and very limited binding was only seen at elevated
temperatures. The differences suggest that there is a functional difference in the
uncoating between the genetic cluster formed by polioviruses and human
enterovirus C species, and the other enteroviruses. The difference may lie in the
uncoating mechanism, or in the channel formation properties of the virus particles,
that may be assisted by cellular compounds.
Two methodological improvements were developed. First, randomization of site-
saturated codons was markedly enhanced by modifying base compositions at the
degenerate positions of the mutagenic primer. Second, cloning strategies were
developed to enable direct transfection of viral genome pools that are otherwise
identical, but have a selected codon randomized. This strategy enables direct
phenotypic selection of the resulting mutant virus populations, and by allowing
simultaneous processing of all mutant genomes, it drastically reduces the laboratory
work needed.
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